SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-283140
Filing Date
2024-12-20
Accepted
2024-12-20 16:21:00
Documents
14
Period of Report
2024-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d905140d8k.htm   iXBRL 8-K 30591
2 EX-10.1 d905140dex101.htm EX-10.1 33525
  Complete submission text file 0001193125-24-283140.txt   201509

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20241219.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20241219_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20241219_pre.xml EX-101.PRE 11708
17 EXTRACTED XBRL INSTANCE DOCUMENT d905140d8k_htm.xml XML 3803
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 241568259
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)